Callion Pharma
Callion Pharma is a privately held dietary supplement company that develops DEKAs and Aqua-E products using proprietary delivery technology to enhance absorption of fat-soluble vitamins A, D, E, and K for patients with malabsorption conditions.
- Company typePrivate
- Founded2015
- HeadquartersJonesborough, United States
- Headcount1–10
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Callion Pharma does
Callion Pharma is a privately held dietary supplement company founded in 2015 and headquartered in Jonesborough, Tennessee, operating as Callion Pharma, LLC under Tennessee law. The company develops and markets branded supplements—principally the DEKAs Plus and DEKAs Essential multivitamin and mineral product lines, alongside Aqua-E Concentrate (a water-soluble vitamin E) and IronUP (a liquid iron product)—targeted at patients with inadequate absorption of fat-soluble vitamins A, D, E, and K, including individuals with cystic fibrosis, liver disease, and other fat-malabsorption disorders. Its technical differentiator is a proprietary delivery technology used across multiple dosage formats (softgels, chewable tablets, liquids, capsules); Aqua-E Concentrate is built on TPGS-based chemistry that solubilizes fat-soluble vitamin E for water-based delivery, and DEKAs Essential Capsules use licensed Licaps liquid-in-capsule technology marketed as fast-absorbing and oxidation-protected.
The business model combines direct-to-consumer sales via the company website and phone ordering with wholesale distribution through the three largest U.S. pharmaceutical wholesalers—Cardinal Health, McKesson, and AmerisourceBergen—for chain and independent pharmacy availability. International reach is delivered through regional distributors across Europe, the Middle East, and Central/South America, with EU/Middle East retail purchases served by a dedicated DEKAsVitamins.com storefront. Unit pricing ranges from $30 to $52 per bottle on a pay-as-you-go basis with no subscription layer. Patient access is widened through partnerships with Abbvie's CFCareForward program, Nestle's LIVE2THRIVE, and the HealthWell Foundation, all of which can supply DEKAs products at no charge to eligible CF and other patients.
Operationally, Callion Pharma is a small privately held LLC with no disclosed funding rounds, headcount, or revenue. Manufacturing is contracted to FDA-inspected sites, with quality control positioned around raw-material sourcing and production documentation. Intellectual property consists of registered trademarks on DEKAs and Aqua-E plus the licensed Licaps mark; no patents on the core delivery technology itself are documented in the inputs. Products are dietary supplements—not drugs or OTC medications—and are marketed for use under physician direction with regular monitoring of vitamin levels.
Callion Pharma firmographics
Firmographics- Name
- Callion Pharma
- Legal name
- Callion Pharma, LLC
- Website
- https://callionpharma.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Callion Pharma is a privately held dietary supplement company that develops DEKAs and Aqua-E products using proprietary delivery technology to enhance absorption of fat-soluble vitamins A, D, E, and K for patients with malabsorption conditions.
- Ownership category
- akta.pro rank
Callion Pharma industry classification
Industry- Product category
- Dietary Supplements
- NAICS
- Food (Health) Supplement Retailers (456191)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity) (CRADAGAE)
- akta.pro secondary industry
- Vitamins (A, B-Complex, C, D, E, K; Premixes) (AFAJAKAA)
Keywords
Where Callion Pharma is headquartered
LocationHeadquarters
- HQ city
- Jonesborough
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Callion Pharma business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D
Revenue model
- Dietary Supplement Sales: Direct-to-consumer and pharmacy channel sales of dietary supplements including DEKAs Plus, DEKAs Essential, Aqua-E Concentrate, and IronUP products. One-time purchase model per product.
- International Distribution: Wholesale distribution through international distributors in Europe, Middle East, and Central/South America. Retail sales in EU and Middle East through DEKAsVitamins.com.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | DEKAs Plus Softgels - 60 softgels |
| Unit Pricing | Pay-as-you-go | DEKAs Plus Liquid - 2 fl oz |
| Unit Pricing | Pay-as-you-go | DEKAs Plus Chewable Tablets - 60 tablets |
| Unit Pricing | Pay-as-you-go | DEKAs Essential Capsules - 60 capsules |
| Unit Pricing | Pay-as-you-go | DEKAs Essential Liquid - 2 fl oz |
| Unit Pricing | Pay-as-you-go | Aqua-E Concentrate - 2 fl oz |
| Unit Pricing | Pay-as-you-go | IronUP - 2 fl oz |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels4 records
Callion Pharma product offering
Product offeringCore offering
Callion Pharma develops and sells advanced dietary supplements under the DEKAs and Aqua-E brands, formulated with proprietary delivery technology to optimize absorption of fat-soluble vitamins D, E, K, and A. Products are targeted at individuals with malabsorption conditions (such as cystic fibrosis, liver disease, and other digestive disorders) and are intended to be used under physician direction with regular monitoring of vitamin levels.
Differentiator
Problem solved
Functional benefit
Brands
- DEKAs Plus: Comprehensive multivitamin and mineral dietary supplements with delivery technology for enhanced absorption of fat-soluble vitamins.
- DEKAs Essential
- Aqua-E
- Aqua-E Concentrate
- IronUP
Products and services
- DEKAs Plus Softgels
Companies that use Callion Pharma
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
Callion Pharma technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Callion Pharma partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- International DistributorscoreCallion Pharma partners with distributors throughout Europe, Middle East, and Central/South America to provide access to products internationally. For EU and Middle East retail, customers directed to DEKAsVitamins.com. Wholesale inquiries handled through [email protected].
- Cardinal HealthcoreMajor pharmaceutical wholesaler distributing Callion Pharma products (DEKAs Plus, DEKAs Essential, Aqua-E, IronUP) to chain and independent pharmacies. Product codes provided for ordering.
- McKessoncoreMajor pharmaceutical wholesaler distributing Callion Pharma products (DEKAs Plus, DEKAs Essential, Aqua-E, IronUP) to chain and independent pharmacies. Product codes provided for ordering.
- AmerisourceBergencoreMajor pharmaceutical wholesaler distributing Callion Pharma products (DEKAs Plus, DEKAs Essential, Aqua-E, IronUP) to chain and independent pharmacies. Product codes provided for ordering.
- Abbvie CFCareForward ProgramminorAbbvie's CFCareForward Program offers Callion Pharma products at no charge to eligible program participants with cystic fibrosis. Contact: 855-227-3493 or creon.com/CFPatients/CFCareForward.
- Nestle LIVE2THRIVEminorNestle's LIVE2THRIVE program offers Callion Pharma products at no charge to eligible program participants. Contact: 888-936-7371 or live2thrive.org.
- HealthWell FoundationminorHealthWell Foundation provides financial assistance for patients with insurance coverage who need help paying for dietary supplements. Callion Pharma accepts direct customer orders with HealthWell ID numbers.
- DEKAsVitamins.comcoreDedicated e-commerce platform for EU and Middle East retail customer purchases of Callion Pharma products including DEKAs vitamins.
Scale indicators2 records
Recent moves5 records
Expansion highlights4 records
Callion Pharma competitors and assessment
Company assessmentDirect peers
- Alcresta Therapeutics: Develops enzyme-based and absorption-enhancing nutritional products for patients with malabsorption and rare diseases, including CF populations. Closely comparable to Callion in addressing fat-soluble vitamin delivery in malabsorption patients.
- Integrative Therapeutics: Professional-grade dietary supplement brand sold through healthcare practitioners and pharmacies. Comparable in channel (HCP-directed, pharmacy distribution) and product category (specialty nutritional supplements).
- Pure Encapsulations: Hypoallergenic, practitioner-recommended supplement brand with strong pharmacy and HCP distribution. Comparable as a privately-held, professionally-positioned supplement manufacturer with similar channel dynamics.
- Metagenics: Medical-grade nutritional supplement company selling through healthcare practitioners with condition-specific formulations. Comparable in practitioner-led GTM and condition-targeted supplement positioning.
- Enzymedica: Specialty enzyme and digestive health supplement brand focused on absorption and digestive conditions. Comparable in its focus on absorption/malabsorption-adjacent conditions and supplement formats.
- Designs for Health: Professional supplement company distributing practitioner-exclusive formulas through HCPs and pharmacies. Comparable in practitioner-led, pharmacy-channel supplement positioning.
Broad incumbents
- Nestlé Health Science: Global medical nutrition business with specialty products for malabsorption, CF, and gastrointestinal conditions, including partnerships like LIVE2THRIVE that overlap with Callion's patient assistance channels. Comparable as a broad incumbent in the same clinical nutrition category.
- AbbVie: Through its CFCareForward program supporting CF patients (which distributes Callion products) and through pancreatic enzyme products like CREON, AbbVie operates adjacent to Callion's CF nutrition niche. Relevant as a broad incumbent shaping CF patient access.
Emerging players
- Solace Nutrition: Specialty nutrition company developing products for malabsorption and gastrointestinal disorders. Comparable as a smaller, focused player in the same clinical nutrition sub-category.
Regional players
- Vitaflo: International medical nutrition company with condition-specific products including for metabolic disorders and malabsorption, primarily serving Europe and other ex-US markets. Comparable as a regional nutrition specialist overlapping Callion's international distributor footprint.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights6 records
Customer concentration
Callion Pharma social profiles
Digital presenceCallion Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Callion Pharma leadership team
Management profileNumber of profiles
Callion Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Callion Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Callion Pharma
What does Callion Pharma do?
Callion Pharma develops and sells advanced dietary supplements under the DEKAs and Aqua-E brands, formulated with proprietary delivery technology to optimize absorption of fat-soluble vitamins D, E, K, and A. Products are targeted at individuals with malabsorption conditions (such as cystic fibrosis, liver disease, and other digestive disorders) and are intended to be used under physician direction with regular monitoring of vitamin levels.
Is Callion Pharma a public or private company?
Callion Pharma is a private company. It is classified as unknown and is currently operating.
When was Callion Pharma founded?
Callion Pharma was founded in 2015. It employs 1 to 10 people.
Where is Callion Pharma based?
Callion Pharma is headquartered in Jonesborough, United States, in the North America region.
How does Callion Pharma make money?
Two revenue lines are on record. Dietary Supplement Sales are the primary driver. The others are international Distribution.
Who are Callion Pharma's main competitors?
Direct peers on record are Alcresta Therapeutics, Integrative Therapeutics, Pure Encapsulations, Metagenics, Enzymedica and Designs for Health. Broad incumbents are Nestlé Health Science and AbbVie. Solace Nutrition is listed as an emerging player. Vitaflo is listed as a regional player.
Does Callion Pharma have an API?
No public API is recorded for Callion Pharma.
What industry is Callion Pharma in?
Callion Pharma's product category is Dietary Supplements. Its primary akta.pro industry code is CRADAGAE, Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity), with a secondary code of AFAJAKAA, Vitamins (A, B-Complex, C, D, E, K; Premixes). Its NAICS code is 456191 and its SIC code is 2833.